These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 15583806)

  • 1. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
    Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
    Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.
    Mylonas I; Makovitzky J; Fernow A; Richter DU; Jeschke U; Briese V; Gerber B; Friese K
    Arch Gynecol Obstet; 2005 Jun; 272(1):59-66. PubMed ID: 15309402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
    Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
    Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.
    Hoeing A; Kuhn C; Shabani N; Schulze S; Gingelmaier A; Dian D; Jeschke U; Friese K; Mylonas I
    Anticancer Res; 2007; 27(4A):2005-10. PubMed ID: 17649813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles.
    Mylonas I; Shabani N; Vogl J; Makovitzky J; Kunze S; Kuhn C; Schulze S; Friese K; Jeschke U
    Anticancer Res; 2007; 27(4A):1995-2000. PubMed ID: 17649811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
    Shim HS; Jung WH; Kim H; Park K; Cho NH
    APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications.
    Mylonas I
    Eur J Cancer; 2010 Sep; 46(13):2485-93. PubMed ID: 20599374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma.
    Gingelmaier A; Gutsche S; Mylonas I; Shabani N; Kuhn C; Kunze S; Jeschke U; Friese K
    Anticancer Res; 2007; 27(4A):2011-7. PubMed ID: 17649814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of inhibins in the endometrial carcinoma cell line RL-95-2 after stimulation with cortisol and estradiol.
    Vogl J; Höing A; Schulze S; Kuhn C; Wiest I; Shabani N; Jeschke U; Mylonas I; Friese K
    Anticancer Res; 2007; 27(4A):1989-93. PubMed ID: 17649810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line.
    Burges A; Shabani N; Brüning A; Mylonas I
    Arch Gynecol Obstet; 2011 Oct; 284(4):981-8. PubMed ID: 21082187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of inhibin/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic, and HELLP pregnancies.
    Mylonas I; Schiessl B; Jeschke U; Vogl J; Makrigiannakis A; Kuhn C; Schulze S; Kainer F; Friese K
    Endocr Pathol; 2006; 17(1):19-33. PubMed ID: 16760577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases.
    Mylonas I; Worbs S; Shabani N; Kuhn C; Kunze S; Schulze S; Dian D; Gingelmaier A; Schindlbeck C; Brüning A; Sommer H; Jeschke U; Friese K
    Eur J Cancer; 2009 May; 45(7):1304-1314. PubMed ID: 19231155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta A versus beta B: is it merely a matter of expression?
    Thompson TB; Cook RW; Chapman SC; Jardetzky TS; Woodruff TK
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):9-17. PubMed ID: 15451562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.